| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Pre-Tax Income
Shanghai MicroPort Endovascular MedTech Group Co Ltd
Pre-Tax Income Peer Comparison
1066
603658
300888
300832
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
| Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Shanghai MicroPort Endovascular MedTech Group Co Ltd
SSE:688016
|
Pre-Tax Income
¥572.3m
|
CAGR 3-Years
32%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Pre-Tax Income
¥2.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
S
|
Shandong Pharmaceutical Glass Co Ltd
SSE:600529
|
Pre-Tax Income
¥986.1m
|
CAGR 3-Years
13%
|
CAGR 5-Years
16%
|
CAGR 10-Years
20%
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Pre-Tax Income
¥1.5B
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Pre-Tax Income
¥749.8m
|
CAGR 3-Years
-45%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Pre-Tax Income
¥1.9B
|
CAGR 3-Years
20%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
See Also
What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Pre-Tax Income?
Pre-Tax Income
572.3m
CNY
Based on the financial report for Dec 31, 2023, Shanghai MicroPort Endovascular MedTech Group Co Ltd's Pre-Tax Income amounts to 572.3m CNY.
What is Shanghai MicroPort Endovascular MedTech Group Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
40%
Over the last year, the Pre-Tax Income growth was 38%. The average annual Pre-Tax Income growth rates for Shanghai MicroPort Endovascular MedTech Group Co Ltd have been 32% over the past three years , 40% over the past five years .
You don't have any saved screeners yet
